Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 28% ± 15% | |
eye | 7 studies | 29% ± 12% | |
kidney | 6 studies | 35% ± 13% | |
intestine | 6 studies | 38% ± 20% | |
uterus | 5 studies | 37% ± 12% | |
brain | 5 studies | 18% ± 2% | |
pancreas | 4 studies | 32% ± 13% | |
placenta | 4 studies | 48% ± 26% | |
prostate | 4 studies | 30% ± 5% | |
skin | 3 studies | 25% ± 6% | |
thymus | 3 studies | 26% ± 4% | |
breast | 3 studies | 23% ± 5% | |
liver | 3 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 7744.02 | 258 / 258 | 100% | 166.69 | 230 / 230 |
ovary | 100% | 11385.88 | 180 / 180 | 100% | 107.56 | 429 / 430 |
thymus | 100% | 4636.15 | 653 / 653 | 99% | 93.98 | 596 / 605 |
brain | 99% | 1690.02 | 2610 / 2642 | 100% | 91.32 | 703 / 705 |
prostate | 100% | 3000.49 | 244 / 245 | 99% | 110.36 | 496 / 502 |
lung | 100% | 3627.57 | 578 / 578 | 98% | 92.76 | 1136 / 1155 |
kidney | 100% | 3161.57 | 89 / 89 | 98% | 81.74 | 885 / 901 |
uterus | 100% | 3418.02 | 170 / 170 | 97% | 119.52 | 444 / 459 |
breast | 100% | 3323.21 | 459 / 459 | 96% | 73.38 | 1070 / 1118 |
skin | 99% | 3250.84 | 1783 / 1809 | 97% | 98.02 | 457 / 472 |
pancreas | 96% | 1152.19 | 315 / 328 | 98% | 99.91 | 175 / 178 |
esophagus | 100% | 2159.90 | 1444 / 1445 | 94% | 91.57 | 172 / 183 |
bladder | 100% | 2881.71 | 21 / 21 | 93% | 117.86 | 470 / 504 |
intestine | 99% | 2252.80 | 960 / 966 | 92% | 65.84 | 485 / 527 |
stomach | 99% | 2086.04 | 357 / 359 | 87% | 59.47 | 249 / 286 |
liver | 51% | 512.01 | 116 / 226 | 67% | 37.93 | 271 / 406 |
spleen | 100% | 2082.43 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 188.55 | 1 / 1 |
blood vessel | 100% | 3868.46 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3264.81 | 1201 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 82.82 | 44 / 45 |
heart | 96% | 1956.61 | 826 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 61.02 | 76 / 80 |
lymph node | 0% | 0 | 0 / 0 | 55% | 16.18 | 16 / 29 |
muscle | 12% | 94.24 | 100 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 9% | 75.50 | 86 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005634 | Cellular component | nucleus |
Gene name | TCEAL9 |
Protein name | Transcription elongation factor A protein-like 9 (TCEA-like protein 9) (Transcription elongation factor S-II protein-like 9) (WW domain-binding protein 5) (WBP-5) |
Synonyms | WBP5 |
Description | FUNCTION: May be involved in transcriptional regulation. . |
Accessions | ENST00000372656.5 ENST00000372661.6 ENST00000646896.1 Q9UHQ7 |